Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-03-19

FDA Approved: OLOPATADINE HYDROCHLORIDE — Supplemental Application (Bausch & Lomb Incorporated)

View source ↗

Summary

The FDA approved a supplemental application for olopatadine hydrochloride ophthalmic solution from Bausch & Lomb, updating the product labeling related to ocula…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OLOPATADINE HYDROCHLORIDE OPHTHALMIC SOLUTION (olopatadine hydrochloride ophthalmic solution)

Snippet

SUPPL AP for OLOPATADINE HYDROCHLORIDE (OLOPATADINE HYDROCHLORIDE)